Searched for
BIOTECH CAREER
“Not Australia, but India rejected me for being a woman”: Kiran Mazumdar-Shaw clarifies how gender bias led her to build Biocon in viral postBiocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...- Failed NEET but made it to Ivy League: Indian woman shares journey to biotech career in USAn Indian woman, Pragya Gupta, shared her inspiring journey of overcoming a NEET exam failure from nearly a decade ago. She detailed how, a...
- Failed NEET in 2016, built a career in the US by 2026: Woman reveals the roadmap that led to success when all felt lostAn Indian woman named Pragya Gupta has gone viral after sharing how her life changed 10 years after failing NEET. In an Instagram video, sh...
- The ‘Inevitables’: Warren Buffett's framework for finding companies that will dominate for decadesWarren Buffett divided the investment universe into Inevitables, Highly Probables, and Impostors. The Inevitables are companies whose domin...
- 'Thank God' Kiran Mazumdar Shaw did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder's inspiring journeyA missed medical college admission propelled Kiran Mazumdar-Shaw towards a different path, ultimately leading to the founding of Biocon. Re...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj ChinthalapellyDheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investm...
- She moved to the US at 11. India-origin CEO in Fortune’s list with Ambani and Adani. Check education and career of Reshma KewalramaniReshma Kewalramani, an Indian-origin CEO, leads Vertex Pharmaceuticals, a Fortune 500 biotech firm, after moving to the US at 11. A Harvard...
- Biotech boom: More Indian students head abroad for biotechnology degreesIndian students are increasingly pursuing biotechnology studies abroad, driven by growing opportunities in gene therapies, vaccines, and we...
- Biocon ranked among top five biotech employers globallyRanked at number five among global pharma and biotech companies in 2020, the Bengaluru-headquartered biopharmaceuticals company said it has...
- Hiring activity sees decline of 62% in April 2020 compared to April 2019: Naukri JobSpeakThe decline in hiring is led by industries like hotel/restaurant/travel/airlines (-91%), auto/ancillary (-82%), retail (-77%) and accountin...
- Biocon number six in top 10 Global Biotech Employers ranking for 2019Biocon continues to be the only company from Asia to feature on the prestigious US-based 'Science' magazine's annual 'Science Careers Top 2...
- How the biopharma twins ended up heading two biopharma companies in MumbaiThe twins studied engineering together at what is now called the National Institute Technology, Trichy which is also the alma mater of N Ch...
- Why Indian entrepreneurs are missing at the top in both biotech and consumer tech cos in Silicon ValleyTechnology becomes more and more important as consumer technology companies grow. Facebook and Twitter now use analytics intensely.
- Indian biotech firms like CyberLiver, Phyto Biotech, others on first major UK missionSeeking to explore tie-ups in the UK's health sector, 18 top Indian biotech and life sciences firms began a first-of-its-kind trade mission...
- Biocon launches programme to train bioscience studentsBiocon Academy will launch the Biocon KGI Certificate Programme in Biosciences next year on January 9 in Claremont, California
- Indian Biotech industry growing at 15% annually, abundant job opportunities'Many pharmaceutical companies have established R&D centers in India and are considering tapping India’s talent', says Lawrence Ganti.
- KPO business to touch $10 bn by 2012: AssochamCurrently, the KPO market size is estimated to be around $5.5 billion and the sector is growing by about 15-17 per cent.
- Geeks help with the math at pharma, biotech companiesRakshit Chaudhary gave up a job offer from TCS & opted for a course in bioinformatics.
Load More
